Complete Story


UPDATED Opioid Laws FAQ's

Changes made to Start Talking Form, MAPS Registration & Use and Acute Pain

LARA and DHHS worked on updating the FAQs regarding the Opioid Laws.  You can find these updated FAQs online at

  • Laws/Regulations
  • Frequently Asked Questions Opioid Laws

Direct link is:,4601,7-154-72600_72603_55478_85991---,00.html


The changes that were made to the FAQs are as follows:


PA 246 of 2017 – Start Talking Form:

Q-5a, Page 6 – Added the word “or unlicensed” to be consistent with what the delegation provision of the Public Health Code, MCL 333.16215. 

Q-5b and 6b, Page 6 – Added:  “Please note that not all prescribers as defined under the Public Health Code have the ability to delegate under the delegation provision of MCL 333.16215.” 

Q-7a, Page 6 – Added:  “Continuation of the established previous therapy does not require a new form.” 

Q-7c, Page 6 – Added: “If the prescriber starts to treat the patient with a new opioid the form would need to be signed and saved in the patient file. 

Q-7d, Page 6 – Added: “When changing the dosage of the same opioid prescription, in a course of treatment, the form would not need to be signed and saved in the patient file.” 

Q-8a, Page 7 – Added:  “For example, administration of the opioid for inpatient stay within, but not limited to, a hospital, freestanding surgical outpatient facility, skilled nursing facility, hospice, homes for aged, etc.” 

Q-8c and  8d, Page 7 – Added: Reference about the Public Health Code definition of “Administer” and definition of “Dispense”. 

PA 248 of 2017 – MAPS Registration & Use:

Q-2b, Page 9 – Added:  “This law does not apply to a prescriber who orders a schedule 2-5 controlled substance for inpatient administration.” 

Q-2c, Page 9 – Added:  Clarified when a licensed veterinarian has to review MAPS. 

Q-2d and 2e, Page 9 – Added:  Reference about the Public Health Code definition of “Administer” and definition of “Dispense”. 

Q-3a and 3b, Pages 9-10 – Added:  New question regarding issuing multiple prescriptions and “do not fill until date”.  

Q-4a, Page 10 – Added:  In addition to the website for MAPS, added reference about training videos also can be found on this site. 

Q-9b, Page 11 – Added:  “Please note it is important that the prescriber reviews the MAPS report prior to prescribing or dispensing a schedule 2-5 controlled substance that exceeds a 3-day supply. 

Q-20b , Page 13 - Added:  “Please note, prescribers and dispensers are not required to save a copy of the MAPS report, whether electronic or hard copy, as the software system that MAPS operates on also has audit trail capabilities.” 

PA 251 of 2017 – Acute Pain:

Q-1c, Page 14 – Added:  “This law does not apply to chronic pain.” 

Q-3a, Page 15 – Added:  Question about whether law applies to veterinarians, which it does not.


Printer-Friendly Version